|
⚲
|
| Keyboard |
| Desjardins Clarissa
✚
|
|
|---|---|
| CIK # | 0001793390 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001793390] | |
| 4 | [0001793390] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Insmed Inc | |
| Desjardins Clarissa | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Insmed Inc INSM
Common Stock
|
2025-05-21 | Buy | 1,130 | $66.35 | 74,976 |
|
Insmed Inc INSM
Common Stock
|
2025-05-20 | Buy | 1,895 | $66.87 | 126,719 |
|
Insmed Inc INSM
Common Stock
|
2025-05-15 | Grant | 5,058 | ||
|
Insmed Inc INSM
Common Stock
|
2024-05-13 | Grant | 13,162 | ||
|
Insmed Inc INSM
Common Stock
|
2023-05-11 | Grant | 13,192 | ||
|
Insmed Inc INSM
Common Stock
|
2022-05-11 | Grant | 14,645 | ||
|
Insmed Inc INSM
Common Stock
|
2021-05-12 | Grant | 7,558 | ||
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2020-06-01 | Grant | 10,000 | $0.00 | |
|
Insmed Inc INSM
Common Stock
|
2020-05-12 | Grant | 8,097 | ||
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2020-01-13 | Grant | 25,000 | $0.00 | |
|
Insmed Inc INSM
Common Stock
|
2019-11-12 | Grant | 5,295 |